Digital health companies must act on health equity. This is the time.

Health equity in America is a vast topic, and I’m sure there are people much more expert in this area than I am. However, as a Black man, and as the CEO of a healthcare technology company that works with thousands of clinical organizations, I believe it’s my obligation to learn, speak out, and take … Read more

Johnson & Johnson’s cancer drug sales help weather hit from stronger dollar

Johnson & Johnson reported quarterly results on Tuesday that beat analysts’ estimates on strength at its pharmaceuticals unit, even as the company cut its full-year adjusted profit forecast due to a stronger dollar. J&J joins other major US multinationals, including Microsoft and IBM, warning of a knock from the strength of the US currency. The … Read more

Diabetes care needs to support lifestyle changes – not pharmaceutical intervention – first

The outsized impact of type 2 diabetes on the health system in the United States is well established – millions of Americans experience declining health and higher healthcare costs each year because of this epidemic and chronic condition. According to the CDC, diabetes costs $327 billion each year and the total cost rose 60% from … Read more

Eisai Announces Key Executive Appointment for Alzheimer’s Disease Leadership

Mr. Fagan joins Eisai with an extensive leadership background and strong record in driving business results. In his new position, he will work closely with internal teams and Eisai’s partners to prepare for the potential launch and growth of a late-stage investigational anti-amyloid protofibril antibody. To fulfill our company’s mission to best serve patients and … Read more

CSafe Global Continues Investment in Cell and Gene Therapy Solutions with Addition of New Portfolio President

Ms. DuRoss brings more than 25 years’ experience to her new position. Prior to joining CSafe, she was the co-founder and CEO of Vineti, an enterprise software platform used to digitize the chain of identity and chain of custody requirements for CGT products. Earlier in her career, DuRoss held several prestigious positions including, Chief Business … Read more

UK remains a key trade market for Ireland since Brexit

The UK was the third largest market for Irish goods exports last year, but was the single largest source of goods imports, a new report shows. Despite Brexit and uncertainty around the Northern Ireland protocol, the latest trade and investment report by the government shows the UK has remained a key trade market for Ireland. … Read more

Abbott is now aiming to recover the baby-formula market share that it lost

Abbott Laboratories ABT, -1.55% is focused on recovering its position in the baby-formula market in the US following the recall that required the intervention of the Biden administration to ensure that parents were able to feed their babies. The recall, which was announced in February, included Similac, EleCare, and other powder-formula products manufactured at one … Read more

Versanis Bio Announces Leadership and Board Appointments as Company Prepares to Initiate Phase 2b Study with Novel Approach to Obesity

Biotech executive and company builder Mark Pruzanski named Chairman and Chief Executive Officer Industry veterans John Maraganore and Barbara Duncan join the Board of Directors NEW YORK, July 20, 2022 /PRNewswire/ — Versanis Bio (“Versanis”), a clinical-stage company advancing novel therapeutics for cardiometabolic diseases, today announced three organizational appointments. Versanis welcomes Mark PruzanskiMD, as Chairman … Read more

Relatient teams up with RCM company to boost provider adoption of patient engagement tech

As provider groups juggle the needs to address competition, staffing shortages and patients ’demand for a consumer-friendly experience, maintaining an effective patient scheduling process is more crucial than ever. That’s according to Jeff Gartland, CEO of patient engagement software company Relative. The Franklin, Tennessee-based company recently announced a referral partnership with TriZetto Provider Solutions to … Read more

Cambridge Innovation Institute Announces the Acquisition of Evaluating Biopharma

Networking and Educational Event Series Join Cambridge Innovation Institute’s Extensive Portfolio NEEDHAM, Mass., July 14, 2022 /PRNewswire/ — Cambridge Innovation Institute (CII) announces the acquisition of Rockville, Maryland-based Evaluating Biopharma (EBP) from BioPlan Associates, Inc. The EBP acquisition includes the properties in its event portfolio as well as its media offerings. Cambridge Innovation Institute acquires … Read more